{
  "actions": [
    {
      "acted_at": "2015-05-19", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2015-05-19", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2015-05-22", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr2433-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "114", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2015-05-19", 
  "number": "2433", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr6-114", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": null, 
  "sponsor": {
    "bioguide_id": "B001257", 
    "district": "12", 
    "name": "Bilirakis, Gus M.", 
    "state": "FL", 
    "thomas_id": "01838", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2015-05-19", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Food and Drug Administration (FDA)", 
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2015-05-19T04:00:00Z", 
    "text": "This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to describe the responsibilities of each agency center charged with reviewing drugs, medical devices, or biological products when reviewing a product that is a combination of drug, medical device, or biological product."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:27:34Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/hr/BILLSTATUS-114hr2433.xml"
}